GLP-1 drugs linked to lower fracture risk in adults with type 2 diabetes
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Oct-2026 14:17 ET (24-Oct-2026 18:17 GMT/UTC)
New research by UCLA Health found GLP-1 medications may reduce the risk of serious fractures for adults with type 2 diabetes.
Dr. Jeffrey Keller, Hibernia National Bank/Edward G. Schleider Endowed Chair at LSU's Pennington Biomedical Research Center, and Sara Seifert, president of Minnesota HealthSolutions, have received a new National Institutes of Health Small Business Innovation Research (SBIR) award to develop an innovative digital health platform that will help parents support teenagers with attention-deficit/hyperactivity disorder (ADHD) as they learn to drive. Teen drivers with ADHD represent one of the highest risk groups for motor vehicle crashes.
The Phase I SBIR award of $353,306, funded by the National Institute of Mental Health, supports the collaboration between Pennington Biomedical and Minnesota HealthSolutions.